METAMIZOLE SODIUM

DRUG3 trials

Sponsors

Cannaxan GmbH, Apurano Pharmaceuticals GmbH, Tauernkliniken GmbH A.ö. Tauernklinikum - Standort Zell am See, Insel Gruppe AG, University Hospital Bern

Conditions

Chronic TonsillitisChronic back painLow Back Pain

Phase 3

Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain

SuspendedCTIS2022-502151-54-00

Cannaxan GmbH, Apurano Pharmaceuticals GmbHChronic back pain

Start: 2023-11-02Target: 558Updated: 2024-11-22

Phase 4

Efficacy of Metamizole Versus Ibuprofen and a Short Educational Intervention Versus Standard Care in Acute Low Back Pain

RecruitingNCT04111315

Insel Gruppe AG, University Hospital BernLow Back Pain

Start: 2019-12-15End: 2025-12-31Target: 120Updated: 2024-02-07

Comparison between Ropivacain and Lidocain used as local anaesthesia regarding postoperative pain outcome after tonsillectomy

RecruitingCTIS2025-520820-44-00

Tauernkliniken GmbH A.ö. Tauernklinikum - Standort Zell am SeeChronic Tonsillitis

Start: 2025-06-26Target: 60Updated: 2025-06-22

Related Papers

Efficacy of metamizole versus ibuprofen and a short educational intervention versus standard care in acute and subacute low back pain: a study protocol of a randomised, multicentre, factorial trial (EMISI trial)

BMJ Open2021-10-018 citations